Covered recipient · General Payments record
WAEL TAHA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$12,947.46
- Reported across 253 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.19 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $76.10 | 2 |
| Amgen Inc. | $57.19 | 2 |
| Novo Nordisk AS | $54.53 | 3 |
| Exact Sciences Corporation | $28.73 | 1 |
| Neurocrine BioSciences, Inc. | $28.29 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.18 | 1 |
| Abbott Laboratories | $23.88 | 1 |
| Lilly USA, LLC | $18.49 | 1 |
| PFIZER INC. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.88 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125132818 | CMS |
| Amgen Inc. | $23.17 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116167619 | CMS |
| Amgen Inc. | $34.02 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116167625 | CMS |
| Exact Sciences Corporation | $28.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114926907 | CMS |
| Lilly USA, LLC | $18.49 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135479293 | CMS |
| Medtronic, Inc. | $25.80 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119382728 | CMS |
| Medtronic, Inc. | $50.30 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119382730 | CMS |
| Neurocrine Biosciences, Inc. | $28.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150829904 | CMS |
| Novo Nordisk Inc | $14.29 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097643814 | CMS |
| Novo Nordisk Inc | $17.19 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096581796 | CMS |
| Novo Nordisk Inc | $23.05 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097688507 | CMS |
| PFIZER INC. | $14.80 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130938068 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.18 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144617193 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.